Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
